Viewing nowCombinationEmpogin Duo Tablet 5/1000 mg (Empagliflozin, Metformin Hydrochloride)
Empagliflozin 5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Samjin Pharmaceutical Co., Ltd.

MFDS item code 202201538 · Approved 2022.04.13 · Insurance code 647805780
Improvement of glycemic control in adults with type 2 diabetes mellitus
This medication aids in improving blood sugar control in adults with type 2 diabetes through the combination of empagliflozin and metformin. It is used as an adjunct to dietary and exercise regimens, particularly suitable for individuals whose blood sugar is not adequately controlled. Additionally, special caution is required regarding its impact on cardiovascular events in type 2 diabetes patients with cardiovascular diseases; please consult a professional for guidance. Overall, this medication helps manage blood sugar more effectively in diabetes treatment.
The recommended dose is 1 tablet twice daily. The dose of this medicine should be determined based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended daily doses of each component: empagliflozin 25 mg and metformin 2000 mg. ⦁ For patients taking this medicine who are unable to achieve adequate glycemic control with metformin alone or in combination with other medicines such as insulin, the recommended dose is empagliflozin 5 mg twice daily (total daily dose 10 mg) and the patient's current metformin dose. If empagliflozin 10 mg (total daily dose) is well tolerated and additional glycemic control is needed, the dose may be increased to empagliflozin 25 mg (total daily dose). ⦁ Patients switching to this medicine from combination therapy with empagliflozin (total daily dose 10 mg or 25 mg) and metformin should receive their current doses of empagliflozin and metformin. When this medicine is coadministered with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see Precautions for Use, 4. Adverse Reactions and 6. Drug Interactions). This medicine should be taken with meals to reduce gastrointestinal adverse reactions associated with metformin. If you miss a dose of this medicine, take it as soon as you remember. However, do not take a double dose at one time; if this occurs, skip the missed dose. Special populations Patients with renal impairment No dose adjustment is necessary for patients with mild renal impairment. Because this medicine contains metformin, it may be used with dose adjustment in patients with an estimated glomerular filtration rate (eGFR) of 45-59 ml/min/1.73m2 or CrCl of 45-59 ml/min who do not have other conditions that may increase the risk of lactic acidosis. Since the starting dose of metformin in these patients is 500 mg or 850 mg once daily, treatment should be initiated with the individual components, empagliflozin and metformin. The maximum daily dose of metformin hydrochloride that may be given with this medicine is 1000 mg, which may be administered as 500 mg twice daily. Renal function should be carefully monitored every 3-6 months (see Precautions for Use, 3. Patients Requiring Caution, item 1)). If renal function declines to CrCl < 45 ml/min or eGFR < 45 ml/min/1.73m2, this medicine should be discontinued immediately (see Precautions for Use, 2. Contraindications, item 2)). Older adults In patients aged 75 years and older, renal function and the risk of volume depletion should be considered.
This medication helps control blood sugar. However, certain precautions should be taken while using it. First, it may cause a rare side effect of severe lactic acidosis, so individuals with impaired kidney function or liver issues should be particularly cautious. Second, when taken with insulin or other diabetes medications, there may be a risk of hypoglycemia, so blood sugar changes should be closely monitored. Third, patients with moderate to severe impaired kidney function or those with acute infections, dehydration, or heart failure should not use this medication. Fourth, before and after surgery or iodine contrast examinations, this medication should be discontinued for a period, and it should be resumed only after normal kidney function has been restored. Fifth, there may be an increased risk of urinary tract infections or genital infections; consult a doctor immediately if infection symptoms occur. Sixth, irregular meals, excessive exercise, and alcohol consumption may increase the risk of hypoglycemia or lactic acidosis; caution is advised. Seventh, it is safest for pregnant or breastfeeding women not to take this medication. Eighth, elderly patients or those with reduced kidney function should have their kidney function regularly checked before and after taking this medication and adjust dosages if necessary. Finally, during treatment with this medication, regular blood tests and checks of physical condition should be conducted, and if any abnormal symptoms occur, medical personnel should be notified immediately.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent exposure to air or moisture. Additionally, it should be kept away from excessively hot or cold places, ideally at room temperature between 1 and 30 degrees Celsius.
Brownish-yellow, bilaterally convex oval film-coated tablets
10 tablets/box [10 tablets/PTP x 1], 60 tablets/box [10 tablets/PTP x 6], 30 tablets/bottle, 60 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationEmpagliflozin 5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Samjin Pharmaceutical Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.